Publications

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

Download PDF
Resource: STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

.

Related Articles

A novel murine syngeneic CD8 peripheral T-cell lymphoma model with preclinical applications

Link
Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections

Link